G Berge

785 total citations
22 papers, 613 citations indexed

About

G Berge is a scholar working on Molecular Biology, Rheumatology and Surgery. According to data from OpenAlex, G Berge has authored 22 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in G Berge's work include Genomics, phytochemicals, and oxidative stress (4 papers), S100 Proteins and Annexins (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). G Berge is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), S100 Proteins and Annexins (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). G Berge collaborates with scholars based in Norway, Germany and United Kingdom. G Berge's co-authors include Aage Haugen, Steen Mollerup, Kjersti Jørgensen, Gunhild M. Mælandsmo, David H. Phillips, Steinar Øvrebø, Alan Hewer, Einar Eilertsen, Sarah Mollerup and Kjetil Boye and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and BMC Cancer.

In The Last Decade

G Berge

22 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Berge Norway 10 266 197 165 128 118 22 613
Laurie Burdette United States 17 397 1.5× 158 0.8× 119 0.7× 111 0.9× 202 1.7× 24 762
Masato Ohshima Japan 19 307 1.2× 163 0.8× 173 1.0× 142 1.1× 223 1.9× 44 873
Mohan C. Pant India 20 539 2.0× 212 1.1× 139 0.8× 70 0.5× 144 1.2× 40 933
Monica Cipollini Italy 14 291 1.1× 113 0.6× 205 1.2× 81 0.6× 166 1.4× 28 709
Kathleen A. Hopp United States 13 276 1.0× 83 0.4× 141 0.9× 52 0.4× 47 0.4× 18 683
Shoichi Inoue Japan 13 284 1.1× 157 0.8× 134 0.8× 37 0.3× 80 0.7× 24 602
H. Lee Taiwan 17 530 2.0× 250 1.3× 92 0.6× 51 0.4× 235 2.0× 21 891
Cheng Su China 16 376 1.4× 116 0.6× 122 0.7× 42 0.3× 127 1.1× 50 725
Haruki Nakazato Japan 13 352 1.3× 162 0.8× 263 1.6× 199 1.6× 97 0.8× 36 776
Camille Mallouh United States 14 225 0.8× 71 0.4× 112 0.7× 53 0.4× 101 0.9× 35 542

Countries citing papers authored by G Berge

Since Specialization
Citations

This map shows the geographic impact of G Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Berge more than expected).

Fields of papers citing papers by G Berge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Berge. The network helps show where G Berge may publish in the future.

Co-authorship network of co-authors of G Berge

This figure shows the co-authorship network connecting the top 25 collaborators of G Berge. A scholar is included among the top collaborators of G Berge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Berge. G Berge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prasmickaite, Lina, G Berge, Steinar Aamdal, et al.. (2015). Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial. Cancer Immunology Immunotherapy. 64(6). 769–776. 5 indexed citations
2.
Boye, Kjetil, Marius Lund‐Iversen, Ann Rita Halvorsen, et al.. (2013). Osteopontin is a prognostic biomarker in non-small cell lung cancer. BMC Cancer. 13(1). 540–540. 43 indexed citations
3.
Lund‐Iversen, Marius, G Berge, Odd Terje Brustugun, et al.. (2012). Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer. BMC Cancer. 12(1). 333–333. 16 indexed citations
4.
Berge, G & Gunhild M. Mælandsmo. (2010). Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53. Amino Acids. 41(4). 863–873. 25 indexed citations
5.
Berge, G, et al.. (2010). Osteopontin—An important downstream effector of S100A4‐mediated invasion and metastasis. International Journal of Cancer. 129(4). 780–790. 50 indexed citations
6.
Berge, G, Daniela Elena Costea, Marianne Berg, et al.. (2010). Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma. Amino Acids. 41(4). 875–884. 10 indexed citations
7.
Mollerup, Steen, G Berge, Vidar Skaug, et al.. (2006). Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. International Journal of Cancer. 119(4). 741–744. 113 indexed citations
8.
Berge, G, Steinar Øvrebø, Einar Eilertsen, Aage Haugen, & Sarah Mollerup. (2004). Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. British Journal of Cancer. 91(7). 1380–1383. 54 indexed citations
9.
Berge, G, Steen Mollerup, Steinar Øvrebø, et al.. (2004). Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung. Lung Cancer. 45(3). 289–297. 37 indexed citations
10.
Berge, G, et al.. (2004). Resveratrol inhibits benzo[a]pyrene–DNA adduct formation in human bronchial epithelial cells. British Journal of Cancer. 91(2). 333–338. 35 indexed citations
11.
Mollerup, Steen, Kjersti Jørgensen, G Berge, & Aage Haugen. (2002). Expression of estrogen receptors α and β in human lung tissue and cell lines. Lung Cancer. 37(2). 153–159. 187 indexed citations
12.
Berge, G, et al.. (2001). Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid. Research in Veterinary Science. 71(1). 27–32. 5 indexed citations
13.
Berge, G, et al.. (2001). Plasma ascorbic acid concentrations in healthy dogs. Research in Veterinary Science. 71(1). 33–35. 6 indexed citations
14.
Berge, G, et al.. (1991). [Malignant metastases on the hand].. PubMed. 116(5). 337–41. 4 indexed citations
15.
Berge, G. (1990). Polyascorbate (C-flex), an alternative treatment for chronic movement disorders in dogs.. 102. 579–581. 1 indexed citations
16.
Berge, G. (1990). Polyascorbate,(C-flex) an alternative by ailments in the support - and movement - structure in dogs. 1 indexed citations
17.
Berge, G, et al.. (1989). [Mammographic findings following reduction mammaplasty].. PubMed. 114(1). 36–9. 5 indexed citations
18.
Berge, G, et al.. (1988). [Results following reduction mammoplasties. A comparison of selected surgical procedures].. PubMed. 113(5). 294–9. 1 indexed citations
19.
Berge, G, et al.. (1985). [Replantation surgery--specific problems, organization and results].. PubMed. 110(12). 764–9. 1 indexed citations
20.
Berge, G, E Brehmer-Andersson, & H Rorsman. (1970). Thalassemia minor and painful ulcers of lower extremities.. PubMed. 50(2). 125–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026